FMOC-DODA*HCI CAS:1274891-99-4 is a highly versatile, bifunctional compound extensively utilized in pharmaceutical research and development. It features two distinct functional groups: a fluorenylmethyloxycarbonyl (Fmoc) protecting group and a 1,4-diaminobutane (DODA) moiety, connected through an amide linkage.
The Fmoc group provides stability and ease of deprotection during solid-phase peptide synthesis (SPPS), while the DODA segment acts as a flexible spacer, capable of introducing diverse functionalities into target molecules. The dihydrochloride salt form ensures increased solubility and handling convenience for various applications.
FMOC-DODA*HCI has gained prominence in the design and synthesis of peptidomimetics, drug delivery systems, and bioconjugates. Its unique structure enables efficient incorporation of pharmacophores, facilitating the development of new therapeutic agents with improved pharmacological profiles.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
![9H-Xanthene-3,6-diamine,9-[4-(chloromethyl)phenyl]-N,N,N',N'-tetramethyl- (9Cl), MitoProbe Orange](https://e1752fbe.rocketcdn.me/wp-content/uploads/AP10583-1-e1685953908485.png)
